CEACAM1 promotes CD8+ T cell responses and improves control of a chronic viral infection
Vishal Khairnar,Vikas Duhan,Ashwini M. Patil,Fan Zhou,Hilal Bhat,Christine Thoens,Piyush Sharma,Tom Adomati,Sarah-Kim Friendrich,Judith Bezgovsek,Janine D. Dreesen,Gunther Wennemuth,Astrid M. Westendorf,Gennadiy Zelinskyy,Ulf Dittmer,Cornelia Hardt,Jörg Timm,Joachim R. Göthert,Philipp A. Lang,Bernhard B. Singer,Karl S. Lang
DOI: https://doi.org/10.1038/s41467-018-04832-2
IF: 16.6
2018-07-02
Nature Communications
Abstract:Dysfunction of CD8+ T cells can lead to the development of chronic viral infection. Identifying mechanisms responsible for such T cell dysfunction is therefore of great importance to understand how to prevent persistent viral infection. Here we show using lymphocytic choriomeningitis virus (LCMV) infection that carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1) is fundamental for recruiting lymphocyte-specific protein kinase (Lck) into the T cell receptor complex to form an efficient immunological synapse. CEACAM1 is essential for activation of CD8+ T cells, and the absence of CEACAM1 on virus-specific CD8+ T cells limits the antiviral CD8+ T cell response. Treatment with anti-CEACAM1 antibody stabilizes Lck in the immunological synapse, prevents CD8+ T cell exhaustion, and improves control of virus infection in vivo. Treatment of human virus-specific CD8+ T cells with anti-CEACAM1 antibody similarly enhances their proliferation. We conclude that CEACAM1 is an important regulator of virus-specific CD8+ T cell functions in mice and humans and represents a promising therapeutic target for modulating CD8+ T cells.
multidisciplinary sciences